{"resourceType":"EvidenceVariable","id":"example-no-alteplase","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;No alteplase\u0026quot; is an intended exposure concept that may be used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"NoAlteplase","title":"no alteplase","status":"draft","description":"no alteplase","actual":false,"characteristic":[{"description":"no alteplase","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"8410","display":"alteplase"}]}}]}
{"resourceType":"EvidenceVariable","id":"example-placebo","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n\t\t\n      \u003cp\u003e\n\t\t\tPlacebo is a specific exposure that may be used in expressing what an Evidence is about.\n\t\t\u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"Placebo","title":"placebo","status":"draft","description":"placebo","actual":true,"characteristic":[{"description":"placebo","definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"182886004","display":"Placebo given (situation)"}]}}]}
{"resourceType":"EvidenceVariable","id":"example-dead-or-dependent-90day","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Dead or functionally dependent at 90 days\u0026quot; is an outcome used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"DeadOrFunctionallyDependentAt90Days","title":"Dead or functionally dependent at 90 days","status":"draft","description":"Dead or functionally dependent at 90 days","actual":false,"characteristic":[{"description":"Dead or functionally dependent at 90 days","definitionByCombination":{"code":"any-of","characteristic":[{"description":"functionally dependent at 90 days","definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"718705001","display":"Functionally dependent (finding)"}]},"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]},{"description":"dead at 90 days","definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"419099009","display":"Dead (finding)"}]},"timeFromEvent":[{"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]}]}}],"handling":"dichotomous"}
{"resourceType":"EvidenceVariable","id":"example-eligibility-criteria-diabetes-surgery","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: EvidenceVariable\u003c/b\u003e\u003ca name\u003d\"example-eligibility-criteria-diabetes-surgery\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource EvidenceVariable \u0026quot;example-eligibility-criteria-diabetes-surgery\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: FEvIR Object Identifier: 32120\u003c/p\u003e\u003cp\u003e\u003cb\u003ename\u003c/b\u003e: StudyEligibilityCriteriaEligibilityCriteriaForBariatricSurgeryRandomizedTrialDiabetesSurgeryStudy\u003c/p\u003e\u003cp\u003e\u003cb\u003etitle\u003c/b\u003e: StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: active\u003c/p\u003e\u003cp\u003e\u003cb\u003epublisher\u003c/b\u003e: Computable Publishing LLC\u003c/p\u003e\u003cp\u003e\u003cb\u003econtact\u003c/b\u003e: \u003ca href\u003d\"mailto:support@computablepublishing.com\"\u003esupport@computablepublishing.com\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Inclusion Criteria:    Age 30 to 67 years at eligibility visit.    Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%.    Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.    Willingness to accept random assignment to either treatment group.    Expect to live or work within approximately one hour\u0027s traveling time from the study clinic for the duration of the two-year trial.    Willingness to comply with the follow-up protocol and successful completion of the run-in.    Written informed consent. ///// Exclusion Criteria:   Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.    Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.    Cardiac stress test indicating that surgery or IMM would not be safe.    Pulmonary embolus or thrombophlebitis in the past six months.    Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.    Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy.    Serum creatinine ≥ 1.5 mg/dl.    HbA1c \u0026gt; 14.0%.\u003c/p\u003e\u003cp\u003e\u003cb\u003ecopyright\u003c/b\u003e: https://creativecommons.org/licenses/by-nc-sa/4.0/\u003c/p\u003e\u003cp\u003e\u003cb\u003eeffectivePeriod\u003c/b\u003e: 2008-02 --\u0026gt; 2016-12\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthor\u003c/b\u003e: Brian S. Alper: \u003c/p\u003e\u003cp\u003e\u003cb\u003eactual\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Age 30 to 67 years at eligibility visit.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eAge \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#397669002)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e30-67 years\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eQuantity\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eat eligibility visit\u003c/td\u003e\u003ctd\u003eEligibilityVisit\u003c/td\u003e\u003ctd\u003e0\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: all-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Diagnosed with T2DM at least 6 months prior to enrollment\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003etimeFromEvent\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: under the active care of a doctor for at least the six months prior to enrollment\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: assumption that active care means active care of type 2 diabetes mellitus\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: under the active care of a doctor \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#305450004 \u0026quot;Under care of doctor (finding)\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003etimeFromEvent\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: HbA1c ≥ 8.0%\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: assumption that this is the last recorded HbA1c before the enrollment visit, but not explicitly stated in the short-phrase Eligibility Criteria\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eBody mass index (BMI) [Ratio] \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#39156-5)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e30-39.9 kg/m2\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eQuantity\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eat eligibility visit\u003c/td\u003e\u003ctd\u003eEligibilityVisit\u003c/td\u003e\u003ctd\u003e0\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Willingness to accept random assignment to either treatment group.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Expect to live or work within approximately one hour\u0027s traveling time from the study clinic for the duration of the two-year trial.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Willingness to comply with the follow-up protocol and successful completion of the run-in.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003elinkId\u003c/b\u003e: EligibilityVisit\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Written informed consent.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: The example used here acknowledges attainment of the written informed consent at the eligibility visit (which is also the time of enrollment) so is referencing this characteristic with the linkId EligibilityVisit to be used as a reference point from timeFromEvent in the specification of other characteristics.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eAssessment of eligibility for clinical trial (procedure) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#450332002)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: any-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: myocardial infarction\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: acute coronary syndrome\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: coronary artery angioplasty or bypass\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: stroke\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003eEligibilityVisit\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiac stress test indicating that surgery or IMM would not be safe.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Pulmonary embolus in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003ePulmonary embolism (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#59282003)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003eEligibilityVisit\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Thrombophlebitis in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eThrombophlebitis (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64156001)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eEvent[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003eEligibilityVisit\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: all-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except basal cell skin cancer)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except cancer in situ)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: unless documented to be disease-free for five years\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: No evidence of cancer found (situation) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#395100000)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003etimeFromEvent\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: History of coagulopathy\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Significant anemia (hemoglobin 1.0 g or more below normal range)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eOffset\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eHemoglobin [Mass/volume] in Blood \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#718-7)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026lt;\u003d-1 g/dL\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code g/dL \u003d \u0027g/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eLower Normal Limit \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"codesystem-characteristic-offset.html\"\u003eCharacteristic Offset\u003c/a\u003e#LNL)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Serum creatinine ≥ 1.5 mg/dl\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eCreatinine [Mass/volume] in Serum or Plasma \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#2160-0)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d1.5 mg/dl\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code mg/dL \u003d \u0027mg/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: HbA1c ≥ 14.0%\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eHemoglobin A1c/Hemoglobin.total in Blood \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#59261-8)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d14 %\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code % \u003d \u0027%\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"identifier":[{"type":{"text":"FEvIR Object Identifier"},"system":"https://fevir.net","value":"32120","assigner":{"display":"Computable Publishing LLC"}}],"name":"StudyEligibilityCriteriaEligibilityCriteriaForBariatricSurgeryRandomizedTrialDiabetesSurgeryStudy","title":"StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)","status":"active","publisher":"Computable Publishing LLC","contact":[{"telecom":[{"system":"email","value":"support@computablepublishing.com"}]}],"description":"Inclusion Criteria:    Age 30 to 67 years at eligibility visit.    Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%.    Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.    Willingness to accept random assignment to either treatment group.    Expect to live or work within approximately one hour\u0027s traveling time from the study clinic for the duration of the two-year trial.    Willingness to comply with the follow-up protocol and successful completion of the run-in.    Written informed consent. ///// Exclusion Criteria:   Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.    Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.    Cardiac stress test indicating that surgery or IMM would not be safe.    Pulmonary embolus or thrombophlebitis in the past six months.    Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.    Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy.    Serum creatinine ≥ 1.5 mg/dl.    HbA1c \u003e 14.0%.","copyright":"https://creativecommons.org/licenses/by-nc-sa/4.0/","effectivePeriod":{"start":"2008-02","end":"2016-12"},"author":[{"name":"Brian S. Alper"}],"actual":true,"characteristic":[{"description":"Age 30 to 67 years at eligibility visit.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"397669002","display":"Age"}]},"valueRange":{"low":{"value":30,"unit":"years","system":"http://unitsofmeasure.org","code":"a"},"high":{"value":67,"unit":"years","system":"http://unitsofmeasure.org","code":"a"}}},"timeFromEvent":[{"description":"at eligibility visit","eventId":"EligibilityVisit","quantity":{"value":0}}]},{"description":"Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%.","exclude":false,"definitionByCombination":{"code":"all-of","characteristic":[{"description":"Diagnosed with T2DM at least 6 months prior to enrollment","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"44054006","display":"Diabetes mellitus type 2 (disorder)"}]}},"timeFromEvent":[{"description":"at least 6 months prior to enrollment","eventId":"EligibilityVisit","quantity":{"value":-6,"comparator":"\u003c\u003d","unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}]},{"description":"under the active care of a doctor for at least the six months prior to enrollment","note":[{"text":"assumption that active care means active care of type 2 diabetes mellitus"}],"exclude":false,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"305450004","display":"Under care of doctor (finding)"}],"text":"under the active care of a doctor"},"timeFromEvent":[{"description":"for at least the six months prior to enrollment","note":[{"text":"presence throughout the range is equivalent to \u0027for at least the six months prior to\u0027"}],"eventCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"450332002","display":"Assessment of eligibility for clinical trial"}]},"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"HbA1c ≥ 8.0%","note":[{"text":"assumption that this is the last recorded HbA1c before the enrollment visit, but not explicitly stated in the short-phrase Eligibility Criteria"}],"exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"59261-8","display":"Hemoglobin A1c/Hemoglobin.total in Blood"}]},"valueQuantity":{"value":8,"comparator":"\u003e\u003d","unit":"%","system":"http://unitsofmeasure.org","code":"%"}}}]}},{"description":"Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueRange":{"low":{"value":30,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"},"high":{"value":39.9,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}},"timeFromEvent":[{"description":"at eligibility visit","eventId":"EligibilityVisit","quantity":{"value":0}}]},{"description":"Willingness to accept random assignment to either treatment group.","exclude":false},{"description":"Expect to live or work within approximately one hour\u0027s traveling time from the study clinic for the duration of the two-year trial.","exclude":false},{"description":"Willingness to comply with the follow-up protocol and successful completion of the run-in.","exclude":false},{"linkId":"EligibilityVisit","description":"Written informed consent.","note":[{"text":"The example used here acknowledges attainment of the written informed consent at the eligibility visit (which is also the time of enrollment) so is referencing this characteristic with the linkId EligibilityVisit to be used as a reference point from timeFromEvent in the specification of other characteristics."}],"exclude":false,"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"450332002","display":"Assessment of eligibility for clinical trial (procedure)"}]}}]},{"description":"Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.","exclude":true,"definitionByCombination":{"code":"any-of","characteristic":[{"description":"myocardial infarction","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"22298006","display":"Myocardial infarction (disorder)"}]}}},{"description":"acute coronary syndrome","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"394659003","display":"Acute coronary syndrome (disorder)"}]}}},{"description":"coronary artery angioplasty or bypass","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"71388002","display":"Procedure (procedure)"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"81266008","display":"Heart revascularization (procedure)"}]}}},{"description":"stroke","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"230690007","display":"Cerebrovascular accident (disorder)"}]}}}]},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"eventId":"EligibilityVisit","range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.","note":[{"text":"This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027"}],"exclude":true},{"description":"Cardiac stress test indicating that surgery or IMM would not be safe.","exclude":true},{"description":"Pulmonary embolus in the past six months.","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"59282003","display":"Pulmonary embolism (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"eventId":"EligibilityVisit","range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Thrombophlebitis in the past six months.","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"64156001","display":"Thrombophlebitis (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"eventId":"EligibilityVisit","range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.","exclude":true,"definitionByCombination":{"code":"all-of","characteristic":[{"description":"Cancer of any kind","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"363346000","display":"Malignant neoplastic disease (disorder)"}]}}},{"description":"(except basal cell skin cancer)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"254701007","display":"Basal cell carcinoma of skin (disorder)"}]}}},{"description":"(except cancer in situ)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"109355002","display":"Carcinoma in situ (disorder)"}]}}},{"description":"unless documented to be disease-free for five years","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"395100000","display":"No evidence of cancer found (situation)"}]},"timeFromEvent":[{"description":"for five years","note":[{"text":"presence throughout the range is equivalent to \u0027for five years"}],"eventId":"EligibilityVisit","range":{"low":{"value":-5,"unit":"years","system":"http://unitsofmeasure.org","code":"a"},"high":{"value":0,"unit":"years","system":"http://unitsofmeasure.org","code":"a"}}}]}]}},{"description":"History of coagulopathy","exclude":true},{"description":"Significant anemia (hemoglobin 1.0 g or more below normal range)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"718-7","display":"Hemoglobin [Mass/volume] in Blood"}]},"valueQuantity":{"value":-1,"comparator":"\u003c\u003d","unit":"g/dL","system":"http://unitsofmeasure.org","code":"g/dL"},"offset":{"coding":[{"system":"http://hl7.org/fhir/characteristic-offset","code":"LNL","display":"Lower Normal Limit"}]}}},{"description":"Serum creatinine ≥ 1.5 mg/dl","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"2160-0","display":"Creatinine [Mass/volume] in Serum or Plasma"}]},"valueQuantity":{"value":1.5,"comparator":"\u003e\u003d","unit":"mg/dl","system":"http://unitsofmeasure.org","code":"mg/dL"}}},{"description":"HbA1c ≥ 14.0%","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"59261-8","display":"Hemoglobin A1c/Hemoglobin.total in Blood"}]},"valueQuantity":{"value":14,"comparator":"\u003e\u003d","unit":"%","system":"http://unitsofmeasure.org","code":"%"}}}]}
{"resourceType":"EvidenceVariable","id":"example-eligibility-criteria-ada-rec-bariatric","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: EvidenceVariable\u003c/b\u003e\u003ca name\u003d\"example-eligibility-criteria-ada-rec-bariatric\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource EvidenceVariable \u0026quot;example-eligibility-criteria-ada-rec-bariatric\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: FEvIR Object Identifier: 32140\u003c/p\u003e\u003cp\u003e\u003cb\u003ename\u003c/b\u003e: RecommendationEligibilityCriteriaEligibilityCriteriaForBariatricSurgeryADARecommendation816\u003c/p\u003e\u003cp\u003e\u003cb\u003etitle\u003c/b\u003e: RecommendationEligibilityCriteria: Eligibility Criteria for Bariatric Surgery (ADA Recommendation 8.16)\u003c/p\u003e\u003cp\u003e\u003cb\u003eshortTitle\u003c/b\u003e: Recommend bariatric surgery if BMI 35 or higher\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: active\u003c/p\u003e\u003cp\u003e\u003cb\u003epublisher\u003c/b\u003e: Computable Publishing LLC\u003c/p\u003e\u003cp\u003e\u003cb\u003econtact\u003c/b\u003e: \u003ca href\u003d\"mailto:support@computablepublishing.com\"\u003esupport@computablepublishing.com\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Inclusion Criteria: [[1]] Adults. [[2]] Diagnosed with type 2 diabetes. [[3]] Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. [[4]] Screened surgical candidates.\u003c/p\u003e\u003cp\u003e\u003cb\u003ecopyright\u003c/b\u003e: https://creativecommons.org/licenses/by-nc-sa/4.0/\u003c/p\u003e\u003cp\u003e\u003cb\u003eeffectivePeriod\u003c/b\u003e: 2021-01 --\u0026gt; (ongoing)\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthor\u003c/b\u003e: Brian S. Alper: \u003c/p\u003e\u003cp\u003e\u003cb\u003eactual\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Adult.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eAge \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#397669002)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d18 years\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code a \u003d \u0027a\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Diagnosed with type 2 diabetes.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eDiabetes mellitus type 2 (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#44054006)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: any-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Body Mass Index (BMI) ≥ 40.0 kg/m2\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 37.5 kg/m2 in Asian Americans\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: any-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: acute coronary heart disease (a value set covering many forms)\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: coronary artery angioplasty or bypass\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: stroke\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027, placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiac stress test indicating that surgery or IMM would not be safe.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: Cardiac stress test indicating that surgery or IMM would not be safe. \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Pulmonary embolus in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003ePulmonary embolism (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#59282003)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Thrombophlebitis in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eThrombophlebitis (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64156001)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: This combination logic fails if the patient has both a basal cell skin cancer or cancer in situ and a cancer of another kind., placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: all-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except basal cell skin cancer)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except cancer in situ)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByTypeAndValue\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: unless documented to be disease-free for five years\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: No evidence of cancer found (situation) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#395100000)\u003c/span\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003etimeFromEvent\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: History of coagulopathy\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: history of coagulopathy \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Significant anemia (hemoglobin 1.0 g or more below normal range)\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eOffset\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eHemoglobin [Mass/volume] in Blood \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#718-7)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026lt;\u003d-1 g/dL\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code g/dL \u003d \u0027g/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eLower Normal Limit \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"codesystem-characteristic-offset.html\"\u003eCharacteristic Offset\u003c/a\u003e#LNL)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Serum creatinine ≥ 1.5 mg/dl\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eCreatinine [Mass/volume] in Serum or Plasma \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#2160-0)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d1.5 mg/dl\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code mg/dL \u003d \u0027mg/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"identifier":[{"type":{"text":"FEvIR Object Identifier"},"system":"https://fevir.net","value":"32140","assigner":{"display":"Computable Publishing LLC"}}],"name":"RecommendationEligibilityCriteriaEligibilityCriteriaForBariatricSurgeryADARecommendation816","title":"RecommendationEligibilityCriteria: Eligibility Criteria for Bariatric Surgery (ADA Recommendation 8.16)","shortTitle":"Recommend bariatric surgery if BMI 35 or higher","status":"active","publisher":"Computable Publishing LLC","contact":[{"telecom":[{"system":"email","value":"support@computablepublishing.com"}]}],"description":"Inclusion Criteria: [[1]] Adults. [[2]] Diagnosed with type 2 diabetes. [[3]] Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. [[4]] Screened surgical candidates.","copyright":"https://creativecommons.org/licenses/by-nc-sa/4.0/","effectivePeriod":{"start":"2021-01"},"author":[{"name":"Brian S. Alper"}],"actual":false,"characteristic":[{"description":"Adult.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"397669002","display":"Age"}]},"valueQuantity":{"value":18,"comparator":"\u003e\u003d","unit":"years","system":"http://unitsofmeasure.org","code":"a"}}},{"description":"Diagnosed with type 2 diabetes.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"44054006","display":"Diabetes mellitus type 2 (disorder)"}]}}},{"description":"Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"any-of","characteristic":[{"description":"Body Mass Index (BMI) ≥ 40.0 kg/m2","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueQuantity":{"value":40,"comparator":"\u003e\u003d","unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}},{"description":"BMI ≥ 37.5 kg/m2 in Asian Americans","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 37.5 kg/m2","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueQuantity":{"value":37.5,"comparator":"\u003e\u003d","unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}},{"linkId":"AsianAmerican","description":"Asian American","note":[{"text":"The evidence and guideline panel decision to modify the BMI threshold for Asian Americans is based on data mostly from Asian Americans not generally including Native Hawaiians and other Pacific Islanders, so it is not explicit whether the modified thresholds apply to Native Hawaiians and other Pacific Islanders. See https://diabetesjournals.org/care/article/38/1/150/37769/BMI-Cut-Points-to-Identify-At-Risk-Asian-Americans for details"}],"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"103579009","display":"Race (observable entity)"}]},"valueCodeableConcept":{"coding":[{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2028-9","display":"Asian"}],"text":"Asian American"}}}]}},{"description":"BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueRange":{"low":{"value":35,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"},"high":{"value":39.9,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}}},{"description":"who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","exclude":true,"definitionCodeableConcept":{"text":"achieving durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods"}}]}},{"description":"BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueRange":{"low":{"value":32.5,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"},"high":{"value":37.4,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}}},{"description":"Asian American","definitionId":"AsianAmerican"},{"description":"who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","exclude":true,"definitionCodeableConcept":{"text":"achieving durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods"}}]}}]}},{"description":"Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByCombination":{"code":"any-of","characteristic":[{"description":"acute coronary heart disease (a value set covering many forms)","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueReference":{"reference":"ValueSet/32152","type":"ValueSet","display":"Acute Coronary Heart Disease Value Set"}}},{"description":"coronary artery angioplasty or bypass","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"71388002","display":"Procedure (procedure)"},{"system":"http://hl7.org/fhir/resource-types","code":"Procedure","display":"Procedure"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"81266008","display":"Heart revascularization (procedure)"}]}}},{"description":"stroke","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"230690007","display":"Cerebrovascular accident (disorder)"}]}}}]},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.","note":[{"text":"This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027"},{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease."}},{"description":"Cardiac stress test indicating that surgery or IMM would not be safe.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"Cardiac stress test indicating that surgery or IMM would not be safe."}},{"description":"Pulmonary embolus in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"59282003","display":"Pulmonary embolism (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Thrombophlebitis in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"64156001","display":"Thrombophlebitis (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.","note":[{"text":"This combination logic fails if the patient has both a basal cell skin cancer or cancer in situ and a cancer of another kind."},{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByCombination":{"code":"all-of","characteristic":[{"description":"Cancer of any kind","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"363346000","display":"Malignant neoplastic disease (disorder)"}]}}},{"description":"(except basal cell skin cancer)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"254701007","display":"Basal cell carcinoma of skin (disorder)"}]}}},{"description":"(except cancer in situ)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"109355002","display":"Carcinoma in situ (disorder)"}]}}},{"description":"unless documented to be disease-free for five years","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"395100000","display":"No evidence of cancer found (situation)"}]},"timeFromEvent":[{"description":"for five years","note":[{"text":"presence throughout the range is equivalent to \u0027for five years\u0027"}],"range":{"low":{"value":-5,"unit":"years","system":"http://unitsofmeasure.org","code":"a"},"high":{"value":0,"unit":"years","system":"http://unitsofmeasure.org","code":"a"}}}]}]}},{"description":"History of coagulopathy","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"history of coagulopathy"}},{"description":"Significant anemia (hemoglobin 1.0 g or more below normal range)","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"718-7","display":"Hemoglobin [Mass/volume] in Blood"}]},"valueQuantity":{"value":-1,"comparator":"\u003c\u003d","unit":"g/dL","system":"http://unitsofmeasure.org","code":"g/dL"},"offset":{"coding":[{"system":"http://hl7.org/fhir/characteristic-offset","code":"LNL","display":"Lower Normal Limit"}]}}},{"description":"Serum creatinine ≥ 1.5 mg/dl","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"2160-0","display":"Creatinine [Mass/volume] in Serum or Plasma"}]},"valueQuantity":{"value":1.5,"comparator":"\u003e\u003d","unit":"mg/dl","system":"http://unitsofmeasure.org","code":"mg/dL"}}}]}
{"resourceType":"EvidenceVariable","id":"example-mRS0-2-at-90days","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;mRS 0-2 at 90 days\u0026quot; is an outcome, defined by a CQL expression, used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"ModifiedRankinScaleScore02At90DaysAfterTreatment","title":"Modified Rankin Scale score 0-2 at 90 days after treatment","status":"draft","description":"Modified Rankin Scale score 0-2 at 90 days after treatment","actual":true,"characteristic":[{"description":"mRS 0-2 at 90 days","definitionExpression":{"description":"mRS 0-2","language":"text/cql","expression":"[\"Observation\": code in \"75859-9|LOINC\"] mRS where mRS.value between 0 and 2"},"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]}],"handling":"dichotomous"}
{"resourceType":"EvidenceVariable","id":"example-alive-independent-90day","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Alive and not functionally dependent at 90 days\u0026quot; is an outcome used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"AliveAndNotFunctionallyDependentAt90Days","title":"Alive and not functionally dependent at 90 days","status":"draft","description":"Alive and not functionally dependent at 90 days","actual":false,"characteristic":[{"description":"not functionally dependent at 90 days","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"718705001","display":"Functionally dependent (finding)"}]},"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]},{"description":"alive at 90 days","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"419099009","display":"Dead (finding)"}]},"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]}],"handling":"dichotomous"}
{"resourceType":"EvidenceVariable","id":"example-alteplase-for-stroke","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Alteplase for Stroke\u0026quot; is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"AlteplaseForStroke","title":"Alteplase for Stroke","status":"draft","description":"Alteplase for Stroke","actual":true,"characteristic":[{"description":"IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour","definitionCanonical":"http://example.org/fhir/ActivityDefinition/example-alteplase-dosing"}]}
{"resourceType":"EvidenceVariable","id":"example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n\t\t  \n      \u003cp\u003e\n\t\t\tStroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis\n\t\t  \u003c/p\u003e\n\t\t\n    \u003c/div\u003e"},"name":"StrokeThrombolysisTrialists20142016IPDMACohort","title":"Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis","status":"draft","description":"Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis","relatedArtifact":[{"type":"citation","label":"Emberson 2014","display":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","citation":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists\u0027 Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063","document":{"url":"https://doi.org/10.1016/S0140-6736(14)60584-5"}},{"type":"citation","label":"Lees 2016","display":"Figure 2 Lees 2016","citation":"Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856","document":{"url":"https://doi.org/10.1161/STROKEAHA.116.013644"}}],"actual":true,"characteristic":[{"description":"Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis","definitionByCombination":{"code":"any-of","characteristic":[{"definitionReference":{"reference":"Group/ECASSIII-Trial-Cohort","type":"Group","display":"ECASS III Trial Cohort"}},{"definitionReference":{"reference":"Group/IST3-Trial-Cohort","type":"Group","display":"IST3 Trial Cohort"}},{"definitionReference":{"reference":"Group/ECASS-Trial-Cohort","type":"Group","display":"ECASS Trial Cohort"}},{"definitionReference":{"reference":"Group/ECASSII-Trial-Cohort","type":"Group","display":"ECASSII Trial Cohort"}},{"definitionReference":{"reference":"Group/EPITHET-Trial-Cohort","type":"Group","display":"EPITHET Trial Cohort"}},{"definitionReference":{"reference":"Group/ATLANTIS-Trial-Cohort","type":"Group","display":"ATLANTIS Trial Cohort"}},{"definitionReference":{"reference":"Group/NINDS-Trial-Cohort","type":"Group","display":"NINDS Trial Cohort"}}]}}]}
{"resourceType":"EvidenceVariable","id":"example-fatal-ICH-in-7-days","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Fatal Intracranial Hemorrhage Within Seven Days\u0026quot; is an outcome used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"FatalIntracranialHemorrhageWithinSevenDays","title":"Fatal Intracranial Hemorrhage Within Seven Days","status":"draft","description":"Fatal Intracranial Hemorrhage Within Seven Days","note":[{"text":"Death must be due to intracranial hemorrhage"}],"actual":true,"characteristic":[{"description":"intracranial hemorrhage within 7 days","definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"1386000","display":"Intracranial hemorrhage (disorder)"}]},"timeFromEvent":[{"description":"within 7 days","eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"range":{"low":{"value":0,"unit":"day","system":"http://unitsofmeasure.org","code":"d"},"high":{"value":7,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}}]},{"description":"death within 7 days","definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"419620001","display":"Death (event)"}]},"timeFromEvent":[{"description":"within 7 days","range":{"low":{"value":0,"unit":"day","system":"http://unitsofmeasure.org","code":"d"},"high":{"value":7,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}}]}],"handling":"dichotomous"}
{"resourceType":"EvidenceVariable","id":"example-Wardlaw2014Analysis1.16.3EvidenceSet","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n\t\t  \n      \u003cp\u003e\n\t\t\t\u0026quot;Wardlaw 2014 Analysis 1.16.3 Evidence set\u0026quot; is a grouping of six Evidence results used in a meta-analysis.\n\t\t  \u003c/p\u003e\n\t\t\n    \u003c/div\u003e"},"name":"Wardlaw2014Analysis1163EvidenceSet","title":"Wardlaw 2014  Analysis 1.16.3  Evidence set","status":"draft","description":"Wardlaw 2014  Analysis 1.16.3  Evidence set","note":[{"text":"Short names for Evidence sources are detailed in \u0027References to studies included in this review\u0027"}],"relatedArtifact":[{"type":"citation","label":"Wardlaw 2014","display":"Analysis 1.16.3 from Wardlaw 2014","citation":"Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jul 29(7):CD000213. PMID 25072528","document":{"url":"https://doi.org/10.1002/14651858.CD000213.pub3"}}],"actual":true,"characteristic":[{"description":"\u0027Wardlaw 2014 Analysis 1.16.3 Evidence set\u0027 is a grouping of six Evidence results used in a meta-analysis.","definitionByCombination":{"code":"any-of","characteristic":[{"definitionReference":{"type":"Evidence","display":"NINDS 1995"}},{"definitionReference":{"type":"Evidence","display":"ECASS 1995"}},{"definitionReference":{"type":"Evidence","display":"ECASS II 1998"}},{"definitionReference":{"type":"Evidence","display":"ATLANTIS B 1999"}},{"definitionReference":{"type":"Evidence","display":"ATLANTIS A 2000"}},{"definitionReference":{"type":"Evidence","display":"IST3 2012"}}]}}],"handling":"dichotomous"}
{"resourceType":"EvidenceVariable","id":"example-eligibility-criteria-adults-with-obesity","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: EvidenceVariable\u003c/b\u003e\u003ca name\u003d\"example-eligibility-criteria-adults-with-obesity\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource EvidenceVariable \u0026quot;example-eligibility-criteria-adults-with-obesity\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: FEvIR Object Identifier: 49218\u003c/p\u003e\u003cp\u003e\u003cb\u003ename\u003c/b\u003e: StudyEligibilityCriteriaObesePatients18YearsOld\u003c/p\u003e\u003cp\u003e\u003cb\u003etitle\u003c/b\u003e: StudyEligibilityCriteria: Obese patients ≥ 18 years old\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: active\u003c/p\u003e\u003cp\u003e\u003cb\u003edate\u003c/b\u003e: 2022-07-24T21:00:00.088Z\u003c/p\u003e\u003cp\u003e\u003cb\u003epublisher\u003c/b\u003e: Computable Publishing LLC\u003c/p\u003e\u003cp\u003e\u003cb\u003econtact\u003c/b\u003e: \u003ca href\u003d\"mailto:support@computablepublishing.com\"\u003esupport@computablepublishing.com\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: obese, adult (age ≥18 years old) patients\u003c/p\u003e\u003cp\u003e\u003cb\u003ecopyright\u003c/b\u003e: https://creativecommons.org/licenses/by-nc-sa/4.0/\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthor\u003c/b\u003e: Brian S. Alper: \u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003erelatedArtifact\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etype\u003c/b\u003e: derived-from\u003c/p\u003e\u003cp\u003e\u003cb\u003elabel\u003c/b\u003e: data source\u003c/p\u003e\u003cp\u003e\u003cb\u003ecitation\u003c/b\u003e: Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis [Journal Article]. Contributors: van Veldhuisen SL, Gorter TM, van Woerden G, de Boer RA, Rienstra M, Hazebroek EJ, van Veldhuisen DJ. In: European heart journal, PMID 35243488. Published March 04, 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/35243488/.\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edocument\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003erelatedArtifact\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etype\u003c/b\u003e: supported-with\u003c/p\u003e\u003cp\u003e\u003cb\u003eclassifier\u003c/b\u003e: Citation Resource for the original article \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edisplay\u003c/b\u003e: Citation Resource for 2022 Systematic Review of bariatric surgery mortality effect - PMID 35243488\u003c/p\u003e\u003cp\u003e\u003cb\u003eresourceReference\u003c/b\u003e: \u003ca href\u003d\"broken-link.html\"\u003eCitation/33400: StudyCitation: 2022 Systematic Review of bariatric surgery mortality effect 35243488\u003c/a\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cp\u003e\u003cb\u003eactual\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: adult (age ≥18 years old)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eCurrent chronological age \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#424144002)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d18 year\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code a \u003d \u0027a\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: obese (Body mass index \u0026gt;\u003d 30 kg/m2)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eBody mass index (BMI) [Ratio] \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#39156-5)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d30 kg/m2\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code kg/m2 \u003d \u0027kg/m2\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"identifier":[{"type":{"text":"FEvIR Object Identifier"},"system":"https://fevir.net","value":"49218","assigner":{"display":"Computable Publishing LLC"}}],"name":"StudyEligibilityCriteriaObesePatients18YearsOld","title":"StudyEligibilityCriteria: Obese patients ≥ 18 years old","status":"active","date":"2022-07-24T21:00:00.088Z","publisher":"Computable Publishing LLC","contact":[{"telecom":[{"system":"email","value":"support@computablepublishing.com"}]}],"description":"obese, adult (age ≥18 years old) patients","copyright":"https://creativecommons.org/licenses/by-nc-sa/4.0/","author":[{"name":"Brian S. Alper"}],"relatedArtifact":[{"type":"derived-from","label":"data source","citation":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis [Journal Article]. Contributors: van Veldhuisen SL, Gorter TM, van Woerden G, de Boer RA, Rienstra M, Hazebroek EJ, van Veldhuisen DJ. In: European heart journal, PMID 35243488. Published March 04, 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/35243488/.","document":{"url":"https://academic.oup.com/eurheartj/article/43/20/1955/6542137"}},{"type":"supported-with","classifier":[{"text":"Citation Resource for the original article"}],"display":"Citation Resource for 2022 Systematic Review of bariatric surgery mortality effect - PMID 35243488","resourceReference":{"reference":"Citation/33400","type":"Citation","display":"StudyCitation: 2022 Systematic Review of bariatric surgery mortality effect 35243488"}}],"actual":true,"characteristic":[{"description":"adult (age ≥18 years old)","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"424144002","display":"Current chronological age"}]},"valueQuantity":{"value":18,"comparator":"\u003e\u003d","unit":"year","system":"http://unitsofmeasure.org","code":"a"}}},{"description":"obese (Body mass index \u003e\u003d 30 kg/m2)","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueQuantity":{"value":30,"comparator":"\u003e\u003d","unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}}]}
{"resourceType":"EvidenceVariable","id":"example-mRS3-6-at-90days","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;mRS 3-6 at 90 days\u0026quot; is an outcome, defined by a CQL expression, used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"},"name":"ModifiedRankinScaleScore36At90DaysAfterTreatment","title":"Modified Rankin Scale score 3-6 at 90 days after treatment","status":"draft","description":"Modified Rankin Scale score 3-6 at 90 days after treatment","actual":true,"characteristic":[{"description":"mRS 3-6 at 90 days","definitionExpression":{"description":"mRS 3-6","language":"text/cql","expression":"[\"Observation\": code in \"75859-9|LOINC\"] mRS where mRS.value between 3 and 6"},"timeFromEvent":[{"eventCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/evidence-variable-event","code":"study-start","display":"Study Start"}]},"quantity":{"value":90,"unit":"day","system":"http://unitsofmeasure.org","code":"d"}}]}],"handling":"dichotomous"}